Zsírmáj (MASLD/MASH): vizsgálatok itt: Kazahsztán

3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Where

  Almaty

  Életkor

  18 év and over

  People

  1800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632444 · EU 2024-513739-25-00
• 3. fázisTaking people
  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Where

  Almaty

  Életkor

  18 év and over

  People

  1590 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT06632457 · EU 2024-513741-36-00
• No phaseTaking people
  Clinical Profile of Patients With MASLD in Kazakhstan and Clinical Effectiveness of Ursosan in Almaty

  Where

  Aktau, Aktobe, Almaty, Astana, Shymkent

  Életkor

  18 év to 65 év

  People

  420

  Run by

  Kazakh Association of Internal Medicine Specialists

  See details and how to joinNCT07889999